SCHEMBL1684162

SCHEMBL1684162

CCN(O)C(=O)c1cc2[nH]cc(Cc3cc(F)c(F)c(F)c3O)c2cn1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1684159 0.84 GPR84 (0.36) GPR84
Ethane SCHEMBL2954432 0.82 GPR84 (0.37) GPR84
SCHEMBL1684208 0.75 ALDH1A1 (0.39)
SCHEMBL28819880 0.65 GABRA1 (0.46) GPR84
SCHEMBL1684121 0.63 RIPK1 (0.46)
Ethane SCHEMBL2948593 0.62 HTR2B (0.34)
SCHEMBL1684143 0.60 RIPK1 (0.42)
SCHEMBL1684122 0.59 RIPK1 (0.43)
SCHEMBL4915074 0.59 GABRA1 (0.46)
SCHEMBL1684160 0.58 SNCA (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041512-A2 COMPOSITIONS AND METHODS FOR TREATING MLV-INFECTION, AND PREVENTING AND TREATING MLV-INITIATED DISEASES EMORY UNIVERSITY (US) 2011-04-07 WO disclosed